Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders
$ 24.00 · 4.5 (292) · In stock
A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.
Mutational signatures of triple-negative breast cancer (TNBC). (A
Understanding the 3D Shape of the Genome Reveals Future Cancer
Treatment of Aggressive Cancer Improved by Sequential Combination
Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer
CRISPR/Cas9 based genome editing for targeted transcriptional
HER2 Positive and Negative Breast Cancers: Aggressiveness
Mount Sinai Team Identify 4,729 Gene Clusters That Influence
Current Oncology, Free Full-Text
What Is Triple-Negative Breast Cancer?
Molecular subtypes and precision treatment of triple-negative
Caris, Hummingbird Bio Collaborate on Anti-HER3 Therapy
Broadening Access to Biomarker Testing to Accelerate Precision
Ultra-Sensitive, Multiplexed Molecular Detection for Biomarker
Renal cell carcinoma Archives - Inside Precision Medicine